Recent Updates
Recently added Catalysts
Fairmount Funds Management LLC
Track Fairmount Funds Management LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Sep 18, 2026
Showing 6 Stocks Out Of 12. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 ORKA | ORUKA THERAPEUTICS INC | 3.71 M | 352.63 M | 23.3 | |
 APGE | APOGEE THERAPEUTICS INC | 298.65 K | 39.64 M | 2.6 | |
 ZBIO | ZENAS BIOPHARMA INC | 2.36 M | 59.87 M | 4 | |
 FTH | FAETH THERAPEUTICS INC | 722.02 K | 18.05 M | 1.2 | |
 ELVN | ENLIVEN THERAPEUTICS INC | 1.86 M | 94.17 M | 6.2 | |
 IKT | INHIBIKASE THERAPEUTICS INC | 8.63 M | 17.51 M | 1.2 |
Market Value
$ 1.51 B
Holdings
12
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
9.29 %